January 6, 2026: Judge Begins Centralization and MDL Processes for Ozempic Vision Loss Lawsuits People who took Ozempic and other GLP-1 drugs and experienced NAION (a sudden partial blindness, usually in one eye) can now join a centralized litigation
Tameika is amazing and really prepares you before and after any service provided
Pecoits-Filho R, Lindholm B, Stenvinkel P
Just a few years ago, you may have only heard about GLP-1 medications (aka Ozempic, Wegovy, Mounjaro, etc.) through tabloid headlines or celebrity gossip forums
According to the IDF Diabetes Atlas, 589 million adults aged 20 to 79 were living with diabetes worldwide in 2024, which is about 1 in 9 adults, and that number is expected to rise to 853 million by 2050
Prescription with diabetes diagnosis (E11.x codes): Likely to be considered for coverage Prescription with obesity diagnosis (E66.x codes): Likely to be denied unless your plan specifically covers weight loss medications Your doctors diagnosis code selection significantly impacts whether your claim is approved or denied